Wharton jelly derived mesenchymal stem cell

BIOLOGICAL2 trials

Sponsors

Hanan Jafar, Ankara Universitesi Teknokent

Conditions

Knee OsteoarthrosisMagnetic Field ExposureMethanol PoisoningStem Cell Tyrosine Kinase 1 Y842XToxic Optic Neuropathy

Phase 1

Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis

Hanan JafarKnee Osteoarthrosis

Start: 2017-01-27End: 2021-12-31Target: 10Updated: 2021-04-28

Phase 3

Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation

CompletedNCT04877067

Ankara Universitesi TeknokentMagnetic Field Exposure, Methanol Poisoning, Stem Cell Tyrosine Kinase 1 Y842X +1

Start: 2019-04-01End: 2021-04-30Updated: 2021-05-10

Related Papers

Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulation

Stem Cell Research & Therapy2021-09-279 citations